Skip to main content
Access Resources

MJFF Publications

1681 - 1690 of 7540 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: Closing the structure-to-function gap for LRRK2
    Journal Name: Trends in Biochemical Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.tibs.2021.10.003
    Citation Count: 2
  • RESTRICTED
    Title: Current Status of Next-Generation Sequencing Approaches for Candidate Gene Discovery in Familial Parkinson´s Disease
    Journal Name: Frontiers in Genetics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fgene.2022.781816
    Citation Count: 3
  • RESTRICTED
    Title: Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial
    Journal Name: The Lancet Microbe
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s2666-5247(21)00239-1
    Citation Count: 34
  • RESTRICTED
    Title: Head tremor in cervical dystonia: Quantifying severity with computer vision
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.jns.2022.120154
    Citation Count: 5
  • RESTRICTED
    Title: How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 Pandemic
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2022.1510
    Citation Count: 5
  • RESTRICTED
    Title: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.022
    Citation Count: 8
  • RESTRICTED
    Title: L1CAM‐associated extracellular vesicles: A systematic review of nomenclature, sources, separation, and characterization
    Journal Name: Journal of Extracellular Biology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/jex2.35
    Citation Count: 39
  • RESTRICTED
    Title: Lessons from metabolic perturbations in lysosomal storage disorders for neurodegeneration
    Journal Name: Current Opinion in Systems Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.coisb.2021.100408
    Best OA location URL:
    Citation Count: 6
  • RESTRICTED
    Title: Llamanade: An open-source computational pipeline for robust nanobody humanization
    Journal Name: Structure
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.str.2021.11.006
    Citation Count: 18
  • RESTRICTED
    Title: Long-term adherence of human brain cells in vitro is enhanced by charged amine-based plasma polymer coatings
    Journal Name: Stem Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.stemcr.2022.01.013
    Citation Count: 11
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.